BGM Group Ltd. SEC filings BGM

BGM Group Ltd. has 154 filings in SEC EDGAR's recent list, going back to Jun 17, 2019. Its latest annual report, Form 20-F, was filed on Jul 21, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Sep 24, 2026. The company's fiscal year ends on September 30.

BGM Group Ltd. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Jun 3, 2025 —
F-3 Shelf registration (foreign issuer) Mar 7, 2025 —
F-3 Shelf registration (foreign issuer) Nov 5, 2024 —
F-3/A Form f-3/a May 8, 2024 —
S-8 Employee stock plan registration Apr 10, 2024 —
F-3 Shelf registration (foreign issuer) Apr 10, 2024 —
424B4 Prospectus Jan 12, 2021 —
F-1/A Filing Dec 23, 2020 —
F-1/A Filing Dec 18, 2020 —
F-1/A Filing Dec 10, 2020 —
FWP Free writing prospectus Dec 9, 2020 —
FWP Free writing prospectus Dec 8, 2020 —
FWP Free writing prospectus Dec 8, 2020 —
F-1/A Filing Nov 23, 2020 —
F-1/A Filing Aug 21, 2020 —
F-1/A Filing Jun 12, 2020 —
F-1/A Filing Apr 8, 2020 —
FWP Free writing prospectus Jan 21, 2020 —
F-1/A Filing Jan 2, 2020 —
F-1/A Filing Nov 27, 2019 —
F-1 Registration statement (foreign issuer) Nov 4, 2019 —

Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BGM (Nasdaq)
Fiscal year ends
September 30
Incorporated in
Cayman Islands
Headquarters
Chengdu
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1779578
Former names
Qilian International Holding Group (until Oct 22, 2024); Qilian International Holding Group Ltd (until Oct 16, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.